🇺🇸 Seretide 500 Accuhaler in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arrhythmia — 1 report (10%)
  2. Cardiac Failure Congestive — 1 report (10%)
  3. Chest Pain — 1 report (10%)
  4. Chronic Obstructive Pulmonary Disease — 1 report (10%)
  5. Cystitis — 1 report (10%)
  6. Dizziness — 1 report (10%)
  7. Headache — 1 report (10%)
  8. Malaise — 1 report (10%)
  9. Pain In Extremity — 1 report (10%)
  10. Pneumonia — 1 report (10%)

Source database →

Other Respiratory / Pulmonology approved in United States

Frequently asked questions

Is Seretide 500 Accuhaler approved in United States?

Seretide 500 Accuhaler does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Seretide 500 Accuhaler in United States?

University of Southampton is the originator. The local marketing authorisation holder may differ — check the official source linked above.